Oncotelic Therapeutics enters consulting agreements with Jefferson Capital and Valor Nation for strategic services

Oncotelic Therapeutics, Inc.

Engaged Jefferson Capital Ventures and Valor Nation for 18-month consulting and advisory services starting August 6, 2025.
Jefferson receives $20,000/month cash and up to 20,320,930 restricted stock awards tied to milestones: market cap >$100M, $10M equity increase, uplisting.
Valor receives 4,064,586 shares of common stock immediately upon signing.
Jefferson's RSAs vest in thirds per milestone; unvested shares forfeited if milestones not achieved.
Shares issued under Section 4(a)(2) exemption from Securities Act registration.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.